This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Radiation dose and image quality performance measures for CT imaging accepted by the U.S. Centers for Medicare and Medicaid Services (CMS) in 2023 are "ambiguous" and need to be reconsidered, according to theAmerican Association of Physicists in Medicine (AAPM). Last month, the association convened what it called "an intersocietal panel of CT experts" -- which included representatives from academia, industry, and professional societies -- to assess a CT data collection/reporting measure that too
The U.S. Food and Drug Administration (FDA) has granted 510(k) clearance to Aikenist Technologies to market its QuickRad AI PACS and RIS with viewer product. The company described the system as a web-based PACS featuring a "Zero Footprint Viewer" with precision measurement tools, structured reporting, and automated AI-assisted diagnosis. It can be deployed on site, in private cloud environments, or on major cloud platforms, and supports FDA-cleared AI algorithms for oncology, neurology, and card
Amidst rising cancer prevalence and soaring costs, new cancer technologies and innovations are emerging to support the early detection, treatment, and surveillance of cancer. Read this guide to understand how to evaluate these solutions for your employees and members – and to learn more about the current state of coverage, clinical and cost effectiveness, and impact on quality and outcomes.
Eckert & Ziegler has entered into an agreement with Actinium Pharmaceuticals to supply the firm with the radioisotope actinium-225 (Ac-225). Actinium will continue developing its lead radiopharmaceutical product Actimab-A, as well as additional early and late-stage development candidates for both U.S. and international clinical trials. Actimab-A is an Ac-225-based radiotherapy agent that is directed against CD33, a receptor overexpressed in patients with acute myeloid leukemia and other myel
A new analysis in Clinical Radiology is intended to help guide interventional radiologists in their decision-making processes regarding PCNB to reduce the likelihood of diagnostic failure.
Researchers in Germany have proposed a new approach derived from brain PET imaging for diagnosing and staging Alzheimers disease, according to a study published March 25 in Radiology. The method is based on the amount of the brain filled with three hallmark pathologic abnormalities associated with the disease amyloid, tau, and neurodegeneration and could become a valuable tool for clinicians, noted first author Elena Doering, MD, of the University of Cologne, and colleagues.
The Academy for Radiology and Biomedical Imaging Research, RSNA members, and early-career investigators are advocating for medical imaging research and facilities and administration (F&A) funding at this year's March 25 Hill Day and #MedTech25 events in Washington, DC. Academy Executive Director Renee Cruea told AuntMinnie.com via email that Hill Day is an opportunity to educate policymakers and their staff about F&A costs, which are on the block for cuts at the U.S.
Patient-centric scheduling can only be achieved through optimized radiology workflows, effective communications between staff and physicians, and, of course, through specialized schedulers. In this guide, we’ll take you through a step-by-step process to transform your radiology center into a high-performance hub of medical imaging.
Weight bearing CT is more than just a modality for functional imaging “its a complete workflow revolution,” for point-of-care access and diagnosis, said Dr. Franois Lintz, MD, PhD, FEBOT. Traditional imaging methods like X-ray can miss up to 40% of fractures, leaving patients undiagnosed for months. With weight bearing CT, clinicians can capture a functional 3D image of a patients anatomy at the point -of-care in just a few minutes, providing a clearer and more accurate picture of t
Evident Vascular has added new investors at the close of a Series B financing round to support the launch of the firm's AI-powered intravascular ultrasound (IVUS) platform in the U.S. The San Jose, CA-based company did not disclose the amount raised in the funding round but said new investor Shangbay Capital and two undisclosed multinational strategics contributed, joining founding investor Vensana Capital.
Attenuation-based biomarkers on computed tomography (CT) scans demonstrated a 93 percent interclass correlation coefficient (ICC) agreement across three pancreatic segmentation algorithms for predicting diabetes, according to a study involving over 9,700 patients.
About 40% of us will be diagnosed with cancer in our lifetime, and patients are getting younger. At the same time, the cost of treatment continues to rise, with employers spending 8.5% more on cancer care for each employee than they did last year. The best thing employers can do for their employees and business tomorrow is to invest in cancer detection and care today.
To evaluate the technical success, safety, and clinical effectiveness of vesical and/or internal iliac artery embolization in patients with intractable hematuria from bladder hemorrhage.
Adjunctive use of the AI-powered software led to an average 38.6 percent increase in the detection of pneumothorax by general radiologists, according to a 2023 study.
Discover how Color's comprehensive care solution is revolutionizing cancer screening adherence and knowledge. Through an in-depth case study, Color's unique approach to comprehensive cancer care has shown significant benefits in increasing screening rates and enhancing patient knowledge. Participants reported a 2-3x increase in adherence to screening guidelines over just 8 weeks, with 84% of participants increasing their familiarity with timing and frequency of cancer screening.
A clinical trial has demonstrated that biopsies guided by high-resolution ultrasound are just as effective as those using MRI for diagnosing prostate cancer.
A clinical trial has demonstrated that biopsies guided by high-resolution ultrasound are just as effective as those using MRI for diagnosing prostate cancer.
A multimodal generative AI model achieved high diagnostic accuracy and showed clinical value in preliminary reporting of chest x-ray images, according to research published March 25 in Radiology. A team led by Eun Kyoung Hong, MD, PhD, from Brigham & Womens Hospital in Boston, MA, found that their domain-specific model could detect conditions such as pneumothorax and subcutaneous emphysema and achieved a high rate of reports accepted without modification from radiologists.
Explore the latest insights from the American Cancer Society's “Cancer Statistics 2024” report, which unveils multiple alarming trends in cancer data. Cancer is on the rise among young adults, and diagnoses for 6 of the 10 most common cancers are escalating. With over 2 million new cancer cases projected in the U.S. this year, employers face increased challenges when it comes to supporting employees.
We organize all of the trending information in your field so you don't have to. Join 5,000 users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
147 
Let's personalize your content